Glimitaz G2 is a combination of Glimepiride (2 mg) and Metformin Hydrochloride (500 mg, sustained release), formulated for the effective management of Type 2 Diabetes Mellitus.
Glimepiride, a sulfonylurea, helps increase insulin secretion from the pancreas, while Metformin, a biguanide, improves insulin sensitivity and reduces hepatic glucose production. This dual mechanism ensures better glycemic control, reduces fasting and postprandial blood sugar levels, and helps lower HbA1c values.
It is an effective, convenient, and affordable oral antidiabetic therapy designed to support long-term diabetes management.
Key Benefits
-
Dual Action Formula – Combines insulin secretion enhancement with improved insulin sensitivity.
-
Better Glycemic Control – Reduces both fasting and post-meal blood glucose levels.
-
Sustained Release (SR) Advantage – Provides prolonged blood sugar control with improved patient compliance.
Reviews
There are no reviews yet.